THERAPY: New data do not support use of abatacept in diabetic nephropathy

    loading  Checking for direct PDF access through Ovid


A new study reports that B7-1 is not expressed on the podocytes of patients or mice with diabetic nephropathy. In contrast to the findings of some previous studies, these data suggest that targeting B7-1 on podocytes using abatacept might not be an appropriate therapeutic strategy for diabetic renal disease.

Related Topics

    loading  Loading Related Articles